Which of the following medications is used to treat acute pancreatitis with necrosis and infection?

Medication Summary

The goal of pharmacotherapy is to relieve pain and minimize complications. Currently, no medications are used to treat acute pancreatitis specifically. Therapy is primarily supportive and involves intravenous (IV) fluid hydration, analgesics, antibiotics (in severe pancreatitis), and treatment of metabolic complications (eg, hyperglycemia and hypocalcemia).

Which of the following medications is used to treat acute pancreatitis with necrosis and infection?

Analgesics, Other

Class Summary

Pain control is essential for quality patient care. It ensures patient comfort, promotes pulmonary toilet, and has sedating properties, which are beneficial for patients who have sustained trauma or have painful lesions. Propoxyphene products were withdrawn from the US market on November 19, 2010. The withdrawal was based on new data showing QT prolongation at therapeutic doses. For more information, see the FDA MedWatch safety information.

Acetaminophen (Tylenol, Feverall, Aspirin Free Anacin)

  • View full drug information

Acetaminophen is a peripherally acting drug of choice for mild to moderate pain and elevation of body temperature.

Tramadol (Ultram, Ryzolt, Rybix)

  • View full drug information

Tramadol is a centrally acting analgesic for moderately severe pain. It inhibits the ascending pain pathways, altering perception of and response to pain. It also inhibits reuptake of norepinephrine and serotonin.

Meperidine (Demerol)

  • View full drug information

Meperidine is a synthetic opioid narcotic analgesic for the relief of severe pain. It has multiple actions similar to those of morphine. It may produce less constipation, smooth muscle spasm, and depression of cough reflex than similar analgesic doses of morphine.

Antibiotics, Other

Class Summary

Antibiotics are used to cover the microorganisms that may grow in biliary pancreatitis and acute necrotizing pancreatitis. The empiric antibiotic regimen is usually based on the premise that enteric anaerobic and aerobic gram-bacilli microorganisms are often the cause of pancreatic infections. Once culture sensitivities are obtained, the antibiotic regimen can be adjusted accordingly.

Imipenem and cilastatin (Primaxin)

  • View full drug information

Imipenem is a thienamycin derivative with greater potency and broader antimicrobial spectrum than other beta-lactam antibiotics. Cilastatin inhibits dehydropeptidase activity and reduces cilastatin metabolism. Imipenem-cilastatin is used for the treatment of multiple-organism infections in which other agents either do not provide wide-spectrum coverage or are contraindicated because of potential toxicity. The 2 agents are generally administered in a 1:1 ratio.

Ampicillin

  • View full drug information

Ampicillin has bactericidal activity against susceptible organisms. It is an alternative to amoxicillin when the patient is unable to take medication orally.

Ceftriaxone (Rocephin)

  • View full drug information

Ceftriaxone is a third-generation cephalosporin with broad-spectrum gram-negative activity; it has lower efficacy against gram-positive organisms and higher efficacy against resistant organisms. Ceftriaxone arrests bacterial growth by binding to 1 or more penicillin-binding proteins.

  1. Telem DA, Bowman K, Hwang J, Chin EH, Nguyen SQ, Divino CM. Selective management of patients with acute biliary pancreatitis. J Gastrointest Surg. 2009 Dec. 13(12):2183-8. [QxMD MEDLINE Link].

  2. Banks PA, Bollen TL, Dervenis C, et al, for the Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan. 62(1):102-11. [QxMD MEDLINE Link].

  3. Haydock MD, Mittal A, van den Heever M, et al, for the Pancreas Network of New Zealand. National survey of fluid therapy in acute pancreatitis: current practice lacks a sound evidence base. World J Surg. 2013 Oct. 37(10):2428-35. [QxMD MEDLINE Link].

  4. Ai X, Qian X, Pan W, et al. Ultrasound-guided percutaneous drainage may decrease the mortality of severe acute pancreatitis. J Gastroenterol. 2010. 45(1):77-85. [QxMD MEDLINE Link].

  5. Li H, Qian Z, Liu Z, Liu X, Han X, Kang H. Risk factors and outcome of acute renal failure in patients with severe acute pancreatitis. J Crit Care. 2010 Jun. 25(2):225-9. [QxMD MEDLINE Link].

  6. Whitcomb DC, Yadav D, Adam S, et al, for the North American Pancreatic Study Group. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatology. 2008. 8(4-5):520-31. [QxMD MEDLINE Link]. [Full Text].

  7. Elmunzer BJ, Scheiman JM, Lehman GA, et al, for the U.S. Cooperative for Outcomes Research in Endoscopy (USCORE). A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012 Apr 12. 366(15):1414-22. [QxMD MEDLINE Link].

  8. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003. 38(10):982-4. [QxMD MEDLINE Link].

  9. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013 Jun. 144(6):1252-61. [QxMD MEDLINE Link]. [Full Text].

  10. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012 Nov. 143(5):1179-1187.e3. [QxMD MEDLINE Link]. [Full Text].

  11. Singla A, Csikesz NG, Simons JP, et al. National hospital volume in acute pancreatitis: analysis of the Nationwide Inpatient Sample 1998-2006. HPB (Oxford). 2009 Aug. 11(5):391-7. [QxMD MEDLINE Link]. [Full Text].

  12. Krishna SG, Kamboj AK, Hart PA, Hinton A, Conwell DL. The changing epidemiology of acute pancreatitis hospitalizations: a decade of trends and the impact of chronic pancreatitis. Pancreas. 2017 Apr. 46(4):482-8. [QxMD MEDLINE Link]. [Full Text].

  13. Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019 Jan. 156(1):254-72.e11. [QxMD MEDLINE Link]. [Full Text].

  14. Banks PA. Epidemiology, natural history, and predictors of disease outcome in acute and chronic pancreatitis. Gastrointest Endosc. 2002 Dec. 56(6 suppl):S226-30. [QxMD MEDLINE Link].

  15. Morinville VD, Barmada MM, Lowe ME. Increasing incidence of acute pancreatitis at an American pediatric tertiary care center: is greater awareness among physicians responsible?. Pancreas. 2010 Jan. 39(1):5-8. [QxMD MEDLINE Link].

  16. Akhtar AJ, Shaheen M. Extrapancreatic manifestations of acute pancreatitis in African-American and Hispanic patients. Pancreas. 2004 Nov. 29(4):291-7. [QxMD MEDLINE Link].

  17. Huh JH, Jeon H, Park SM, et al. Diabetes mellitus is associated with mortality in acute pancreatitis. J Clin Gastroenterol. 2018 Feb. 52(2):178-83. [QxMD MEDLINE Link].

  18. Whitcomb DC. Clinical practice. Acute pancreatitis. N Engl J Med. 2006 May 18. 354(20):2142-50. [QxMD MEDLINE Link].

  19. Suppiah A, Malde D, Arab T, et al. The prognostic value of the neutrophil-lymphocyte ratio (NLR) in acute pancreatitis: identification of an optimal NLR. J Gastrointest Surg. 2013 Apr. 17(4):675-81. [QxMD MEDLINE Link].

  20. Khan A, Sarma D, Gowda C, Rodrigues G. The role of Modified Early Warning Score (MEWS) in the prognosis of acute pancreatitis. Oman Med J. 2021 May. 36(3):e272. [QxMD MEDLINE Link]. [Full Text].

  21. Mikolasevic I, Orlic L, Poropat G, et al. Nonalcoholic fatty liver and the severity of acute pancreatitis. Eur J Intern Med. 2017 Mar. 38:73-8. [QxMD MEDLINE Link].

  22. Kothari S, Kalinowski M, Kobeszko M, Almouradi T. Computed tomography scan imaging in diagnosing acute uncomplicated pancreatitis: Usefulness vs cost. World J Gastroenterol. 2019 Mar 7. 25(9):1080-7. [QxMD MEDLINE Link]. [Full Text].

  23. Imamura Y, Hirota M, Ida S, et al. Significance of renal rim grade on computed tomography in severity evaluation of acute pancreatitis. Pancreas. 2010 Jan. 39(1):41-6. [QxMD MEDLINE Link].

  24. Balthazar EJ, Ranson JH, Naidich DP, Megibow AJ, Caccavale R, Cooper MM. Acute pancreatitis: prognostic value of CT. Radiology. 1985 Sep. 156(3):767-72. [QxMD MEDLINE Link].

  25. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990 Feb. 174(2):331-6. [QxMD MEDLINE Link].

  26. Balthazar EJ. Staging of acute pancreatitis. Radiol Clin North Am. 2002 Dec. 40(6):1199-209. [QxMD MEDLINE Link].

  27. Badalov N, Tenner S, Baillie J. The prevention, recognition and treatment of post-ERCP pancreatitis. JOP. 2009 Mar 9. 10(2):88-97. [QxMD MEDLINE Link].

  28. Testoni PA, Mariani A, Giussani A, et al, for the SEIFRED Group. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am J Gastroenterol. 2010 Aug. 105(8):1753-61. [QxMD MEDLINE Link].

  29. Parihar V, Ridgway PF, Conlon KC, Huggett M, Ryan BM. The role of endoscopic intervention in the management of inflammatory pancreatic fluid collections. Eur J Gastroenterol Hepatol. 2017 Apr. 29(4):371-9. [QxMD MEDLINE Link].

  30. Imrie CW. Prognostic indicators in acute pancreatitis. Can J Gastroenterol. 2003 May. 17(5):325-8. [QxMD MEDLINE Link].

  31. Krishnan K. Nutritional management of acute pancreatitis. Curr Opin Gastroenterol. 2017 Mar. 33(2):102-6. [QxMD MEDLINE Link].

  32. Jacobson BC, Vander Vliet MB, Hughes MD, Maurer R, McManus K, Banks PA. A prospective, randomized trial of clear liquids versus low-fat solid diet as the initial meal in mild acute pancreatitis. Clin Gastroenterol Hepatol. 2007 Aug. 5(8):946-51; quiz 886. [QxMD MEDLINE Link]. [Full Text].

  33. Bakker OJ, van Brunschot S, van Santvoort HC, et al, for the Dutch Pancreatitis Study Group. Early versus on-demand nasoenteric tube feeding in acute pancreatitis. N Engl J Med. 2014 Nov 20. 371(21):1983-93. [QxMD MEDLINE Link].

  34. Maravi-Poma E, Gener J, Alvarez-Lerma F, et al, for the Spanish Group for the Study of Septic Complications in Severe Acute Pancreatitis. Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin. Intensive Care Med. 2003 Nov. 29(11):1974-80. [QxMD MEDLINE Link].

  35. Isenmann R, Runzi M, Kron M, et al, for the German Antibiotics in Severe Acute Pancreatitis Study Group. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology. 2004 Apr. 126(4):997-1004. [QxMD MEDLINE Link].

  36. Johnson CD, Kingsnorth AN, Imrie CW, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut. 2001 Jan. 48(1):62-9. [QxMD MEDLINE Link]. [Full Text].

  37. Aboulian A, Chan T, Yaghoubian A, et al. Early cholecystectomy safely decreases hospital stay in patients with mild gallstone pancreatitis: a randomized prospective study. Ann Surg. 2010 Apr. 251(4):615-9. [QxMD MEDLINE Link].

  38. Guadagni S, Cengeli I, Palmeri M, et al. Early cholecystectomy for non-severe acute gallstone pancreatitis: easier said than done. Minerva Chir. 2017 Apr. 72(2):91-7. [QxMD MEDLINE Link].

  39. van Santvoort HC, Besselink MG, Bakker OJ, et al, for the Dutch Pancreatitis Study Group. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010 Apr 22. 362(16):1491-502. [QxMD MEDLINE Link].

  40. [Guideline] Tenner S, Baillie J, DeWitt J, Vege SS, and the American College of Gastroenterology. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013 Sep. 108(9):1400-15; 1416. [QxMD MEDLINE Link].

  41. [Guideline] Crockett SD, Wani S, Gardner TB, Falck-Ytter Y, Barkun AN, American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis. Gastroenterology. 2018 Mar. 154(4):1096-101. [QxMD MEDLINE Link].

  42. [Guideline] Vege SS, Ziring B, Jain R, Moayyedi P, and the Clinical Guidelines Committee, American Gastroenterology Association. American Gastroenterological Association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015 Apr. 148(4):819-22; quiz 12-3. [QxMD MEDLINE Link].

  43. [Guideline] Leppaniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019. 14:27. [QxMD MEDLINE Link]. [Full Text].

  44. Granger J, Remick D. Acute pancreatitis: models, markers, and mediators. Shock. 2005 Dec. 24 suppl 1:45-51. [QxMD MEDLINE Link].

  45. Wu BU, Hwang JQ, Gardner TH, et al. Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011 Aug. 9(8):710-7.e1. [QxMD MEDLINE Link].

  46. Kim SB, Kim TN, Chung HH, Kim KH. Small gallstone size and delayed cholecystectomy increase the risk of recurrent pancreatobiliary complications after resolved acute biliary pancreatitis. Dig Dis Sci. 2017 Mar. 62(3):777-83. [QxMD MEDLINE Link].

  47. Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 2019 Mar. 16(3):175-84. [QxMD MEDLINE Link]. [Full Text].

  48. Machicado JD, Yadav D. Epidemiology of recurrent acute and chronic pancreatitis: similarities and differences. Dig Dis Sci. 2017 Jul. 62(7):1683-91. [QxMD MEDLINE Link]. [Full Text].

  49. [Guideline] Vege SS, DiMagno MJ, Forsmark CE, Martel M, Barkun AN. Initial medical treatment of acute pancreatitis: American Gastroenterological Association Institute Technical Review. Gastroenterology. 2018 Mar. 154(4):1103-39. [QxMD MEDLINE Link].

  50. Jeon CY, Papachristou GI, Pisegna JR, et al. A Case-CrossovEr study deSign to inform tailored interventions to prevent disease progression in Acute Pancreatitis (ACCESS-AP) - study design and population. Pancreatology. 2021 Jun 24. [QxMD MEDLINE Link].

  51. Duzenci D, Yalnız M, Ispiroglu M. Comparison between prognostic indicators in organ insufficiency with acute pancreatitis. Ulus Travma Acil Cerrahi Derg. 2021 Jul. 27(4):410-20. [QxMD MEDLINE Link].

Author

Coauthor(s)

Chief Editor

Acknowledgements

Tushar Patel, MB, ChB Professor of Medicine, Ohio State University Medical Center

Tushar Patel, MB, ChB is a member of the following medical societies: American Association for the Study of Liver Diseases and American Gastroenterological Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Noel Williams, MD Professor Emeritus, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Professor, Department of Internal Medicine, Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada

Noel Williams, MD is a member of the following medical societies: Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Paul Yakshe, MD Assistant Professor of Medicine, University of Minnesota, Medical Director of Pancreas and Biliary Clinic, Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Fairview University Medical Center

Paul Yakshe, MD is a member of the following medical societies: American College of Gastroenterology, American Pancreatic Association, and American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

What are the main drugs that are used for acute pancreatitis?

Omnipen (ampicillin), Primaxin Iv (imipenem/cilastatin), and Rocephin (ceftriaxone sodium) are commonly prescribed for pancreatitis and require a prescription.

What is the treatment for pancreatic necrosis?

Surgery remains the gold standard in the treatment of infected pancreatic necrosis, 48 and necrosectomy and continuous closed lavage was successful in 67% of our patients with infected necrosis.

What antibiotics are used for necrotizing pancreatitis?

In patients with infected necrosis, administer antibiotics known to penetrate pancreatic necrosis (eg, carbapenems, quinolones, metronidazole), which may delay or avoid intervention, thereby decreasing morbidity and mortality.

What is the best treatment for acute pancreatitis?

Treatment for Pancreatitis.
a hospital stay to treat dehydration with intravenous (IV) fluids and, if you can swallow them, fluids by mouth..
pain medicine, and antibiotics by mouth or through an IV if you have an infection in your pancreas..
a low-fat diet, or nutrition by feeding tube or IV if you can't eat..